4//SEC Filing
RUBINSTEIN JULIE 4
Accession 0001062993-23-006323
CIK 0001478320other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:01 PM ET
Size
8.6 KB
Accession
0001062993-23-006323
Insider Transaction Report
Form 4
RUBINSTEIN JULIE
President and COO
Transactions
- Award
Common Stock
2023-03-06+132,979→ 359,492 total - Award
Stock Option (right to buy)
2023-03-06+199,549→ 199,549 totalExercise: $8.46Exp: 2033-03-06→ Common Stock (199,549 underlying) - Sale
Common Stock
2023-03-06$8.57/sh−22,668$194,265→ 336,824 total
Footnotes (2)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereunder at the end of each full month of continuous service until fully vested.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780664
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 8:01 PM ET
- Size
- 8.6 KB